
Hai L. Nguyen
Examiner (ID: 3, Phone: (571)272-1747 , Office: P/2842 )
| Most Active Art Unit | 2842 |
| Art Unit(s) | 2842, 2816 |
| Total Applications | 2273 |
| Issued Applications | 2006 |
| Pending Applications | 70 |
| Abandoned Applications | 222 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18374328
[patent_doc_number] => 20230149407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => Methods of Treating Coronavirus Disease 2019
[patent_app_type] => utility
[patent_app_number] => 17/907707
[patent_app_country] => US
[patent_app_date] => 2021-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24064
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17907707
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/907707 | Methods of Treating Coronavirus Disease 2019 | Mar 31, 2021 | Abandoned |
Array
(
[id] => 17200058
[patent_doc_number] => 20210340153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => SEMISYNTHETIC METHODS OF PREPARING GTX1,4 AND NEOSAXITOXIN
[patent_app_type] => utility
[patent_app_number] => 17/212690
[patent_app_country] => US
[patent_app_date] => 2021-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10685
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17212690
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/212690 | Semisynthetic methods of preparing GTX1,4 and neosaxitoxin | Mar 24, 2021 | Issued |
Array
(
[id] => 18323669
[patent_doc_number] => 20230121797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-20
[patent_title] => A COMBINATION OF FLAVONOIDS AND SPHINGOSINE 1 PHOSPHATE LYASE INHIBITORS FOR THE TREATMENT OF LUNG INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 17/914469
[patent_app_country] => US
[patent_app_date] => 2021-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9925
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17914469
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/914469 | A COMBINATION OF FLAVONOIDS AND SPHINGOSINE 1 PHOSPHATE LYASE INHIBITORS FOR THE TREATMENT OF LUNG INFLAMMATION | Mar 24, 2021 | Abandoned |
Array
(
[id] => 17178329
[patent_doc_number] => 11155563
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-26
[patent_title] => Macrocyclic compounds and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/213093
[patent_app_country] => US
[patent_app_date] => 2021-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 25665
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17213093
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/213093 | Macrocyclic compounds and uses thereof | Mar 24, 2021 | Issued |
Array
(
[id] => 17784628
[patent_doc_number] => 11407740
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Antibacterial compounds
[patent_app_type] => utility
[patent_app_number] => 17/205750
[patent_app_country] => US
[patent_app_date] => 2021-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24736
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 344
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17205750
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/205750 | Antibacterial compounds | Mar 17, 2021 | Issued |
Array
(
[id] => 18345625
[patent_doc_number] => 20230133735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => USE OF PYRROLOPYRIMIDINE COMPOUND FOR TREATING HEMOPHAGOCYTIC SYNDROME
[patent_app_type] => utility
[patent_app_number] => 17/910331
[patent_app_country] => US
[patent_app_date] => 2021-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5358
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17910331
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/910331 | Use of pyrrolopyrimidine compound for treating hemophagocytic syndrome | Mar 8, 2021 | Issued |
Array
(
[id] => 16915729
[patent_doc_number] => 20210188821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => JAK1 SELECTIVE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/188097
[patent_app_country] => US
[patent_app_date] => 2021-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30784
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188097
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/188097 | JAK1 selective inhibitors | Feb 28, 2021 | Issued |
Array
(
[id] => 19339343
[patent_doc_number] => 12049521
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-30
[patent_title] => Hybrid cyclic libraries and screens thereof
[patent_app_type] => utility
[patent_app_number] => 17/185658
[patent_app_country] => US
[patent_app_date] => 2021-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19466
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17185658
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/185658 | Hybrid cyclic libraries and screens thereof | Feb 24, 2021 | Issued |
Array
(
[id] => 16915755
[patent_doc_number] => 20210188847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => 3-SUBSTITUTED PROPIONIC ACIDS AS ALPHA V INTEGRIN INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/184179
[patent_app_country] => US
[patent_app_date] => 2021-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72898
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17184179
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/184179 | 3-substituted propionic acids as aV integrin inhibitors | Feb 23, 2021 | Issued |
Array
(
[id] => 16900626
[patent_doc_number] => 20210179542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => 4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/249171
[patent_app_country] => US
[patent_app_date] => 2021-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 275
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17249171
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/249171 | 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases | Feb 21, 2021 | Issued |
Array
(
[id] => 18504588
[patent_doc_number] => 11702392
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-18
[patent_title] => Pyrimidinone derivatives as SHP2 antagonists
[patent_app_type] => utility
[patent_app_number] => 17/181614
[patent_app_country] => US
[patent_app_date] => 2021-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 36188
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17181614
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/181614 | Pyrimidinone derivatives as SHP2 antagonists | Feb 21, 2021 | Issued |
Array
(
[id] => 17451800
[patent_doc_number] => 11266635
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-08
[patent_title] => Methods of treating gastrointestinal stromal tumors
[patent_app_type] => utility
[patent_app_number] => 17/180218
[patent_app_country] => US
[patent_app_date] => 2021-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 54
[patent_no_of_words] => 17129
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17180218
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/180218 | Methods of treating gastrointestinal stromal tumors | Feb 18, 2021 | Issued |
Array
(
[id] => 17473907
[patent_doc_number] => 20220081411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => Substituted 4-Benzyl And 4-Benzoyl Piperidine Derivates
[patent_app_type] => utility
[patent_app_number] => 17/175751
[patent_app_country] => US
[patent_app_date] => 2021-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57624
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 395
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17175751
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/175751 | Substituted 4-benzyl and 4-benzoyl piperidine derivates | Feb 14, 2021 | Issued |
Array
(
[id] => 17945701
[patent_doc_number] => 20220332718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS
[patent_app_type] => utility
[patent_app_number] => 17/172766
[patent_app_country] => US
[patent_app_date] => 2021-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 130998
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 689
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17172766
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/172766 | PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS | Feb 9, 2021 | Abandoned |
Array
(
[id] => 19165791
[patent_doc_number] => 11981677
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-05-14
[patent_title] => Further substituted triazolo quinoxaline derivatives
[patent_app_type] => utility
[patent_app_number] => 17/171520
[patent_app_country] => US
[patent_app_date] => 2021-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37630
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17171520
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/171520 | Further substituted triazolo quinoxaline derivatives | Feb 8, 2021 | Issued |
Array
(
[id] => 19354072
[patent_doc_number] => 12054501
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-06
[patent_title] => Compositions and methods for inhibiting arginase activity
[patent_app_type] => utility
[patent_app_number] => 17/153804
[patent_app_country] => US
[patent_app_date] => 2021-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 26813
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17153804
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/153804 | Compositions and methods for inhibiting arginase activity | Jan 19, 2021 | Issued |
Array
(
[id] => 18948118
[patent_doc_number] => 11891399
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-06
[patent_title] => Inhibitors of cancer invasion, attachment, and/or metastasis
[patent_app_type] => utility
[patent_app_number] => 17/148813
[patent_app_country] => US
[patent_app_date] => 2021-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 88
[patent_figures_cnt] => 160
[patent_no_of_words] => 114019
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 699
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17148813
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/148813 | Inhibitors of cancer invasion, attachment, and/or metastasis | Jan 13, 2021 | Issued |
Array
(
[id] => 20172979
[patent_doc_number] => 12391711
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-19
[patent_title] => Tetrahydrocannabinol derivatives, preparation method thereof and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/772993
[patent_app_country] => US
[patent_app_date] => 2021-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3593
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 835
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17772993
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/772993 | Tetrahydrocannabinol derivatives, preparation method thereof and use thereof | Jan 6, 2021 | Issued |
Array
(
[id] => 19564744
[patent_doc_number] => 12139505
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-12
[patent_title] => Compositions useful in therapy of autophagy-related pathologies, and methods of making and using the same
[patent_app_type] => utility
[patent_app_number] => 17/140789
[patent_app_country] => US
[patent_app_date] => 2021-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 53
[patent_no_of_words] => 29596
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17140789
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/140789 | Compositions useful in therapy of autophagy-related pathologies, and methods of making and using the same | Jan 3, 2021 | Issued |
Array
(
[id] => 18779074
[patent_doc_number] => 11820767
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-21
[patent_title] => Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection
[patent_app_type] => utility
[patent_app_number] => 17/135927
[patent_app_country] => US
[patent_app_date] => 2020-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 8
[patent_no_of_words] => 22268
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17135927
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/135927 | Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection | Dec 27, 2020 | Issued |